Merck appoints new board execs

German drug maker Merck announced the promotion of Mr Stefan Oschmann (57) to the position of deputy CEO and vice chairman of the executive board


(Photo Courtesy:

Concurrently, Ms Belén Garijo (54) was appointed to the executive board to take over leadership for the pharma business.

The management changes will become effective as of January 1, 2015.

Mr Oschmann, currently CEO pharma, will represent Mr Karl-Ludwig Kley, chairman of the executive board.

Both will share strategic management functions and will represent the company with politicians and international organizations.

As a member of the executive board, Ms Garijo, currently CEO of Merck's biopharmaceutical division Merck Serono, will take on responsibility for the whole pharma business. Besides Merck Serono, this includes consumer health, allergy and biosimilars.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email